![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » ASTRA EARNINGS JUMP 49 PERCENT
ASTRA EARNINGS JUMP 49 PERCENT
AstraZeneca Plc (AZN.L: Quote, Profile, Research) proved its reputation for above-average growth with a 49 percent jump in third-quarter earnings per share on Thursday, driven by a tight control of costs. Sales, however, fell short of expectations, dampening enthusiasm for the stock. Europe's third biggest drug maker increased its full-year outlook for earnings to $2.85-2.95 a share, from more than $2.75 a share previously, as margins at the group continued to improve.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct